FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Amnon Zisman

Research Profile

Disorders

Procedures

Concepts & Ideas

Anatomy

Living Beings

Chemicals & Drugs

Interleukin-2

Co-author Network

Publications

TOP 3
Tobias Klatte; Allan J Pantuck; Jonathan W Said; David B Seligson; Nagesh P Rao; Jeffrey C La Rochelle; Brian Shuch; Amnon Zisman; Fairooz Kabbinavar; Arie S Belldegrun
Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma.
John S Lam; Tobias Klatte; Hyung L Kim; Jean-Jacques Patard; Alberto Breda; Amnon Zisman; Allan J Pantuck; Robert A Figlin
Prognostic factors and selection for clinical studies of patients with kidney cancer.
Tobias Klatte; Heiko Wunderlich; Jean-Jacques Patard; Mark D Kleid; John S Lam; Kerstin Junker; Jörg Schubert; Malte Böhm; Ernst Peter Allhoff; Fairooz Kabbinavar; Maxime Crepel; Luca Cindolo; Alexandre de la Taille; Jacques Tostain; Arnaud Mejean; Michel Soulie; Laurent Bellec; Jean Christophe Bernhard; Jean-Marie Ferriere; Christian Pfister; Baptiste Albouy; Marc Colombel; Amnon Zisman; Arie S Belldegrun; Allan J Pantuck
Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Amnon Zisman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Tobias Klatte; Allan J Pantuck; Jonathan W Said; David B Seligson; Nagesh P Rao; Jeffrey C La Rochelle; Brian Shuch; Amnon Zisman; Fairooz Kabbinavar; Arie S Belldegrun
Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(4):1162-9.
2008: John S Lam; Tobias Klatte; Hyung L Kim; Jean-Jacques Patard; Alberto Breda; Amnon Zisman; Allan J Pantuck; Robert A Figlin
Prognostic factors and selection for clinical studies of patients with kidney cancer.
Critical reviews in oncology/hematology 2008;65(3):235-62.
2007: Tobias Klatte; Heiko Wunderlich; Jean-Jacques Patard; Mark D Kleid; John S Lam; Kerstin Junker; Jörg Schubert; Malte Böhm; Ernst Peter Allhoff; Fairooz Kabbinavar; Maxime Crepel; Luca Cindolo; Alexandre de la Taille; Jacques Tostain; Arnaud Mejean; Michel Soulie; Laurent Bellec; Jean Christophe Bernhard; Jean-Marie Ferriere; Christian Pfister; Baptiste Albouy; Marc Colombel; Amnon Zisman; Arie S Belldegrun; Allan J Pantuck
Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience.
BJU international 2007;100(1):21-5.
2007: Tobias Klatte; Jean-Jacques Patard; Heiko Wunderlich; Rakhee H Goel; John S Lam; Kerstin Junker; Jörg Schubert; Malte Böhm; Ernst Peter Allhoff; Fairooz Kabbinavar; Maxime Crepel; Luca Cindolo; Alexandre de la Taille; Jacques Tostain; Arnaud Mejean; Michel Soulie; Laurent Bellec; Jean Christophe Bernhard; Jean-Marie Ferriere; Christian Pfister; Baptiste Albouy; Marc Colombel; Amnon Zisman; Arie S Belldegrun; Allan J Pantuck
Metachronous bilateral renal cell carcinoma: risk assessment, prognosis and relevance of the primary-free interval.
The Journal of urology 2007;177(6):2081-6; discussion 2086-7.
2004: Ken-Ryu Han; Nicolette K Janzen; Valerie C McWhorter; Hyung L Kim; Allan J Pantuck; Amnon Zisman; Robert A Figlin; Frederick J Dorey; Jonathan W Said; Arie S Belldegrun
Cystic renal cell carcinoma: biology and clinical behavior.
Urologic oncology 2004;22(5):410-4.
2004: Hyung L Kim; Ken-Ryu Han; Amnon Zisman; Robert A Figlin; Arie S Belldegrun
Cachexia-like symptoms predict a worse prognosis in localized t1 renal cell carcinoma.
The Journal of urology 2004;171(5):1810-3.
2004: Hyung L Kim; Amnon Zisman; Ken-Ryu Han; Robert A Figlin; Arie S Belldegrun
Prognostic significance of venous thrombus in renal cell carcinoma. Are renal vein and inferior vena cava involvement different?
The Journal of urology 2004;171(2 Pt 1):588-91.
2003: Ken-Ryu Han; Ivar Bleumer; Allan J Pantuck; Hyung L Kim; Frederick J Dorey; Nicolette K Janzen; Amnon Zisman; Colin P N Dinney; Christopher G Wood; David A Swanson; Jonathan W Said; Robert A Figlin; Peter F A Mulders; Arie S Belldegrun
Validation of an integrated staging system toward improved prognostication of patients with localized renal cell carcinoma in an international population.
The Journal of urology 2003;170(6 Pt 1):2221-4.
2003: Ken-Ryu Han; Jeff K Cohen; Ralph J Miller; Allan J Pantuck; Danielo G Freitas; Carlos A Cuevas; Hyung L Kim; James Lugg; Stacy J Childs; Barry Shuman; Maury A Jayson; Neal D Shore; Yan Moore; Amnon Zisman; Joe Y Lee; Roland Ugarte; Lance A Mynderse; Torrence M Wilson; Susan D Sweat; Horst Zincke; Arie S Belldegrun
Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience.
The Journal of urology 2003;170(4 Pt 1):1126-30.
2003: Barbara J Gitlitz; Arie S Belldegrun; Amnon Zisman; Debby H Chao; Allan J Pantuck; Andreas Hinkel; Peter F A Mulders; Nancy Moldawer; Cho-Lea Tso; Robert A Figlin
A pilot trial of tumor lysate-loaded dendritic cells for the treatment of metastatic renal cell carcinoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2003;26(5):412-9.
2003: Amnon Zisman; Allan J Pantuck; Matthew H T Bui; Jonathan W Said; Randy Caliliw; Nagesh Rao; Peter Shintaku; Frank Berger; Sanjiv S Gambhir; Arie S Belldegrun
LABAZ1: A metastatic tumor model for renal cell carcinoma expressing the carbonic anhydrase type 9 tumor antigen.
Cancer research 2003;63(16):4952-9.
2003: Bradley C Leibovich; Allan J Pantuck; Matthew H T Bui; Ken Ryu-Han; Amnon Zisman; Robert Figlin; Arie Belldegrun
Current staging of renal cell carcinoma.
The Urologic clinics of North America 2003;30(3):481-97, viii.
2003: Allan J Pantuck; Amnon Zisman; Frederick Dorey; Debby H Chao; Ken-Ryu Han; Jonathan Said; Barbara J Gitlitz; Arie S Belldegrun; Robert A Figlin
Renal cell carcinoma with retroperitoneal lymph nodes. Impact on survival and benefits of immunotherapy.
Cancer 2003;97(12):2995-3002.
2003: Allan J Pantuck; Amnon Zisman; Frederick Dorey; Debby H Chao; Ken-Ryu Han; Jonathan Said; Barbara J Gitlitz; Robert A Figlin; Arie S Belldegrun
Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection.
The Journal of urology 2003;169(6):2076-83.
2003: Stephen J Freedland; Allan J Pantuck; Sun H Paik; Amnon Zisman; Thomas G Graeber; David Eisenberg; william mcbride; David Nguyen; Cho-Lea Tso; Arie S Belldegrun
Heterogeneity of molecular targets on clonal cancer lines derived from a novel hormone-refractory prostate cancer tumor system.
The Prostate 2003;55(4):299-307.
2003: Stephen J Freedland; David Seligson; Alvin Y Liu; Allan J Pantuck; Sun H Paik; Steve Horvath; Jeffrey A Wieder; Amnon Zisman; David Nguyen; Cho-Lea Tso; Aarno V Palotie; Arie S Belldegrun
Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer.
The Prostate 2003;55(1):71-80.
2003: Amnon Zisman; Jeff A Wieder; Allan J Pantuck; Debby H Chao; Frederick Dorey; Jonathan W Said; Barbara J Gitlitz; Jean B deKernion; Robert A Figlin; Arie S Belldegrun
Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy and response to immunotherapy.
The Journal of urology 2003;169(3):909-16.
2003: Ken-Ryu Han; Matthew H T Bui; Allan J Pantuck; Danielo G Freitas; Bradley C Leibovich; Frederick J Dorey; Amnon Zisman; Nicolette K Janzen; Hideki Mukouyama; Robert A Figlin; Aie S Belldegrun
TNM T3a renal cell carcinoma: adrenal gland involvement is not the same as renal fat invasion.
The Journal of urology 2003;169(3):899-903; discussion 903-4.
2003: Ken-Ryu Han; Allan J Pantuck; Matthew H T Bui; Oleg Shvarts; Danielo G Freitas; Amnon Zisman; Bradley C Leibovich; Frederick J Dorey; Barbara J Gitlitz; Robert A Figlin; Arie S Belldegrun
Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma.
Urology 2003;61(2):314-9.
2002: Kent T Perry; Amnon Zisman; H Albin Gritsch; Allan J Pantuck; Peter Schulam
Use of heparin and protamine sulfate during laparoscopic donor nephrectomy.
Transplantation 2002;74(12):1700-2.
2002: Amnon Zisman; Allan J Pantuck; Jeffery Wieder; Debby H Chao; Frederick Dorey; Jonathan W Said; Jean B deKernion; Robert A Figlin; Arie S Belldegrun
Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(23):4559-66.
2002: Chuen-Pei Ng; Amnon Zisman; Benjamin Bonavida
Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance.
The Prostate 2002;53(4):286-99.
2002: Allan J Pantuck; Frank Berger; Amnon Zisman; David Nguyen; Cho-Lea Tso; Jamie Matherly; Sanjiv S Gambhir; Arie S Belldegrun
CL1-SR39: A noninvasive molecular imaging model of prostate cancer suicide gene therapy using positron emission tomography.
The Journal of urology 2002;168(3):1193-8.
2002: Amnon Zisman; Allan J Pantuck; Debby H Chao; Jeff A Wieder; Frederick Dorey; Jonathan W Said; Jean B Kernion; Robert Figlin; Arie S Belldegrun
Renal cell carcinoma with tumor thrombus: is cytoreductive nephrectomy for advanced disease associated with an increased complication rate?
The Journal of urology 2002;168(3):962-7.
2002: Amnon Zisman; Debby H Chao; Allan J Pantuck; Hyun J Kim; Jeff A Wieder; Robert A Figlin; Jonathan W Said; Arie S Belldegrun
Unclassified renal cell carcinoma: clinical features and prognostic impact of a new histological subtype.
The Journal of urology 2002;168(3):950-5.
2002: Kent T Perry; Amnon Zisman; Jennifer Singer; Peter Schulam
Splenosis presenting as a right suprarenal retroperitoneal mass.
The Journal of urology 2002;168(2):644-5.
2002: Debby H Chao; Amnon Zisman; Allan J Pantuck; Stephen J Freedland; Jonathan W Said; Arie S Belldegrun
Changing concepts in the management of renal oncocytoma.
Urology 2002;59(5):635-42.
2002: Allan J Pantuck; Jamie Matherly; Amnon Zisman; David Nguyen; Frank Berger; Sanjiv S Gambhir; Margaret E Black; Arie Belldegrun; Lily Wu
Optimizing prostate cancer suicide gene therapy using herpes simplex virus thymidine kinase active site variants.
Human gene therapy 2002;13(7):777-89.
2002: Amnon Zisman; Allan J Pantuck; Frederick Dorey; Debby H Chao; Barbara J Gitlitz; Nancy Moldawer; Dana Lazarovici; Jean B deKernion; Robert A Figlin; Arie S Belldegrun
Mathematical model to predict individual survival for patients with renal cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(5):1368-74.
2002: Nicolette K Janzen; Amnon Zisman; Allan J Pantuck; Kent Perry; Peter Schulam; Arie S Belldegrun
Minimally invasive ablative approaches in the treatment of renal cell carcinoma.
Current urology reports 2002;3(1):13-20.
2002: Kent Perry; Amnon Zisman; Allan J Pantuck; Nicolette K Janzen; Peter Schulam; Arie S Belldegrun
Laparoscopic and percutaneous ablative techniques in the treatment of renal cell carcinoma.
Reviews in urology 2002;4(3):103-11.
2002: Allan J Pantuck; Amnon Zisman; Jeffrey Cohen; Arie Belldegrun
Cryosurgical ablation of renal tumors using 1.5-millimeter, ultrathin cryoprobes.
Urology 2002;59(1):130-3.
2002: Debby Chao; Amnon Zisman; Allan J Pantuck; Barbara J Gitlitz; Stephen J Freedland; Jonathan W Said; Robert A Figlin; Arie S Belldegrun
Collecting duct renal cell carcinoma: clinical study of a rare tumor.
The Journal of urology 2002;167(1):71-4.
2001: Amnon Zisman; Allan J Pantuck; J K Cohen; Arie S Belldegrun
Prostate cryoablation using direct transperineal placement of ultrathin probes through a 17-gauge brachytherapy template-technique and preliminary results.
Urology 2001;58(6):988-93.
2001: Amnon Zisman; C P Ng; Allan J Pantuck; B Bonavida; Arie S Belldegrun
Actinomycin D and gemcitabine synergistically sensitize androgen-independent prostate cancer cells to Apo2L/TRAIL-mediated apoptosis.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2001;24(6):459-71.
2001: Cho-Lea Tso; Amnon Zisman; Allan J Pantuck; R Calilliw; J M Hernandez; S Paik; David Nguyen; Barbara J Gitlitz; Peter Shintaku; Jean B De Kernion; Robert Figlin; Arie Belldegrun
Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Cancer research 2001;61(21):7925-33.
2001: Allan J Pantuck; Amnon Zisman; Arie S Belldegrun
The changing natural history of renal cell carcinoma.
The Journal of urology 2001;166(5):1611-23.
2001: Amnon Zisman; Allan J Pantuck; D Chao; Frederick Dorey; Jonathan W Said; Barbara J Gitlitz; Jean B De Kernion; Robert A Figlin; Arie S Belldegrun
Reevaluation of the 1997 TNM classification for renal cell carcinoma: T1 and T2 cutoff point at 4.5 rather than 7 cm. better correlates with clinical outcome.
The Journal of urology 2001;166(1):54-8.
2001: S J Freedland; Allan J Pantuck; J Weider; Amnon Zisman; Arie S Belldegrun
Immunotherapy of prostate cancer.
Current urology reports 2001;2(3):242-7.
2001: Arie Belldegrun; Cho-Lea Tso; Amnon Zisman; J Naitoh; Jonathan Said; Allan J Pantuck; Andreas Hinkel; Jean B deKernion; Robert Figlin
Interleukin 2 gene therapy for prostate cancer: phase I clinical trial and basic biology.
Human gene therapy 2001;12(8):883-92.
2001: Allan J Pantuck; Amnon Zisman; D Henderson; D Wilson; A Schreiber; Arie Belldegrun
New biologicals for prostate cancer prevention: Genes, vaccines, and immune-based interventions.
Urology 2001;57(4 Suppl 1):95-9.
2001: Amnon Zisman; Allan J Pantuck; Frederick Dorey; Jonathan W Said; Oleg Shvarts; D Quintana; Barbara J Gitlitz; Jean B deKernion; Robert A Figlin; Arie S Belldegrun
Improved prognostication of renal cell carcinoma using an integrated staging system.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(6):1649-57.
2000: B J Patel; Allan J Pantuck; Amnon Zisman; Ke-hung Tsui; Sun H Paik; Randy Caliliw; S Sheriff; Lily Wu; Jean B deKernion; Cho-Lea Tso; Arie S Belldegrun
CL1-GFP: an androgen independent metastatic tumor model for prostate cancer.
The Journal of urology 2000;164(4):1420-5.
2000: Allan J Pantuck; Amnon Zisman; M K Rauch; Arie Belldegrun
Incidental renal tumors.
Urology 2000;56(2):190-6.
2000: Allan J Pantuck; Amnon Zisman; Arie S Belldegrun
Gene therapy for prostate cancer at the University of California, Los Angeles: preliminary results and future directions.
World journal of urology 2000;18(2):143-7.